Evidence map›Paper›PMID 40280719›Full record

ArticleCancer genomics & proteomics

Association of Matrix Metalloproteinase-2 Promoter Genotypes With Leiomyoma Risk.

Shu-Yu Chang, Wen-Shin Chang, Chia-Wen Tsai, Yun-Chi Wang, Hou-Yu Shih, Chen-Hsien Su, DA-Tian Bau

Abstract read
In one paragraph

Article in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shu-Yu Chang *Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Wen-Shin Chang *Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Chia-Wen Tsai *Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Yun-Chi WangGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Hou-Yu ShihGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
Chen-Hsien SuTerry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
DA-Tian BauGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; 013280@tool.caaumed.org.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThe role of matrix metalloproteinase-2 (MMP-2) in leiomyoma pathogenesis has been suggested, but the association between MATERIALS AND

methods

resultsGenotypic distributions of

conclusion

Indexed as

Genetic Predisposition to DiseaseLeiomyomaMatrix Metalloproteinase 2Promoter Regions, GeneticUterine NeoplasmsAdultCase-Control StudiesFemaleGenotypeHumansMiddle AgedPolymorphism, Single NucleotideRisk FactorsMatrix Metalloproteinase 2MMP2 protein, humanGenotypeleiomyomamatrix metalloproteinase-2polymorphismTaiwan

Identifiers

PMID40280719
PMCPMC12041871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.